Author:
Boin Francesco,Rosen Antony
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Wigley FM, Hummers LK: Clinical features of systemic sclerosis. In Rheumatology, 3rd edition. Edited by Hochberg MC, Silman AJ, Smolen JS, et al. St. Louis: Mosby; 2003:1463–1480.
2. Harris ML, Rosen A: Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies. Curr Opin Rheumatol 2003, 15:778–784.
3. Hu PQ, Fertig N, Medsger TA Jr, et al.: Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum 2003, 48:1363–1373.
4. Zhou X, Tan F, Milewicz DM, et al.: Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the “scleroderma phenotype.” J Immunol 2005, 175:4555–4560.
5. Baroni SS, Santillo M, Bevilacqua F, et al.: Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006, 354:2667–2676.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献